Management of Newly Diagnosed Cirrhosis

Diuretic Therapy for Ascites Management

The European Association for the Study of the Liver recommends spironolactone monotherapy (starting dose 100 mg, increased up to 400 mg as needed) for first presentation of moderate ascites 1, 3
For recurrent severe ascites or when faster diuresis is needed, combination therapy with spironolactone (starting dose 100 mg) and furosemide (starting dose 40 mg) is recommended 1, 3
Patients should be monitored closely for adverse events with diuretic therapy, as nearly half may require dose reduction or discontinuation 3

Beta-blockers should be used cautiously in patients with advanced decompensation as they may compromise renal function and hemodynamic stability 2

The American Association for the Study of Liver Diseases recommends primary prophylaxis with antibiotics to prevent spontaneous bacterial peritonitis (SBP) in patients with cirrhosis and ascites with protein count <1.5 g/dL 1, 3
Patients presenting with gastrointestinal bleeding and underlying ascites should receive prophylactic antibiotic treatment (cefotaxime is widely studied, but choice should be based on local resistance patterns) 1, 2, 3
Patients who have recovered from an episode of SBP should be considered for secondary prophylaxis with norfloxacin (400 mg once daily), ciprofloxacin (500 mg once daily), or co-trimoxazole (800 mg sulfamethoxazole and 160 mg trimethoprim daily) 1, 3

Patients should be placed on a moderately salt-restricted diet with daily salt intake of no more than 5-6.5 g (87-113 mmol sodium) 1, 3
Nutritional counseling on sodium content in the diet should be provided 1, 3
Fluid restriction to 1-1.5 L/day should be reserved for patients with severe hyponatremia (serum sodium <125 mmol/L) 1, 3

For acute variceal hemorrhage, vasoactive drugs (terlipressin, somatostatin, or octreotide) should be initiated as soon as bleeding is suspected 4, 5
These drugs should be continued for 2-5 days after initial endoscopic hemostasis to prevent early rebleeding 5

In patients with spontaneous bacterial peritonitis and increased or rising serum creatinine, albumin infusion (1.5 g/kg within 6 hours of diagnosis) should be administered 1

Patients with CTP class A cirrhosis should be considered for antiviral treatment if viral hepatitis is the underlying cause, as HCV eradication decreases the risk of long-term complications 6
Even after successful treatment and reaching SVR, continuous monitoring for cirrhosis-related complications and HCC is needed 6
Patients with refractory ascites may benefit from midodrine on a case-by-case basis 3